Current issues of RNAi therapeutics delivery and development.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMID 25111131)

Published in J Control Release on August 09, 2014

Authors

D Haussecker1

Author Affiliations

1: Independent RNAi Therapeutics Analyst and Consultant, Rastatt, Germany. Electronic address: dirk.haussecker@gmail.com.

Articles citing this

Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA. Nat Microbiol (2016) 1.40

Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension. J Control Release (2015) 0.92

Towards a new era in medicine: therapeutic genome editing. Genome Biol (2015) 0.83

Production and clinical development of nanoparticles for gene delivery. Mol Ther Methods Clin Dev (2016) 0.82

A High-Throughput Method for Direct Detection of Therapeutic Oligonucleotide-Induced Gene Silencing In Vivo. Nucleic Acid Ther (2015) 0.81

DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing. Nat Commun (2015) 0.81

Effect of surface properties on liposomal siRNA delivery. Biomaterials (2015) 0.80

Technologies for controlled, local delivery of siRNA. J Control Release (2015) 0.80

Imaging-guided delivery of RNAi for anticancer treatment. Adv Drug Deliv Rev (2016) 0.79

RNA Viruses and RNAi: Quasispecies Implications for Viral Escape. Viruses (2015) 0.78

Biodistribution and pharmacokinetics of Mad2 siRNA-loaded EGFR-targeted chitosan nanoparticles in cisplatin sensitive and resistant lung cancer models. Nanomedicine (Lond) (2016) 0.77

Hydrophobic interactions between polymeric carrier and palmitic acid-conjugated siRNA improve PEGylated polyplex stability and enhance in vivo pharmacokinetics and tumor gene silencing. Biomaterials (2016) 0.76

Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines. Adv Drug Deliv Rev (2015) 0.76

Deciphering fact from artifact when using reporter assays to investigate the roles of host factors on L1 retrotransposition. Mob DNA (2016) 0.75

Efficient delivery of Notch1 siRNA to SKOV3 cells by cationic cholesterol derivative-based liposome. Int J Nanomedicine (2016) 0.75

Efficient delivery of DNA into bovine preimplantation embryos by multiwall carbon nanotubes. Sci Rep (2016) 0.75

Multistep, effective drug distribution within solid tumors. Oncotarget (2015) 0.75

Targeting Microtubules for Wound Repair. Adv Wound Care (New Rochelle) (2016) 0.75

siRNA Delivery Strategies: A Comprehensive Review of Recent Developments. Nanomaterials (Basel) (2017) 0.75

RNAi therapy to the wall of arteries and veins: anatomical, physiologic, and pharmacological considerations. J Transl Med (2017) 0.75

A biodistribution study of solid lipid-polyethyleneimine hybrid nanocarrier for cancer RNAi therapy. Eur J Pharm Biopharm (2016) 0.75